FDA Mandates Nationwide Breast Density Notification
A new FDA regulation requires all U.S. mammography facilities to notify patients of their breast density levels, prompting radiologists to play a critical role in educating patients about the associated cancer risks, the need for additional screening options, and how breast density changes over time.